切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2017, Vol. 10 ›› Issue (05) : 597 -600. doi: 10.3877/cma.j.issn.1674-6902.2017.05.027

所属专题: 文献

综述

哮喘-慢性阻塞性肺疾病重叠的诊疗进展
李瑞丽1, 华毛2,(), 冯喜英2, 马维秀2, 李寒1   
  1. 1. 810001 西宁,青海大学研究生院
    2. 810001 西宁,青海大学附属医院呼吸内科
  • 收稿日期:2017-05-22 出版日期:2017-10-20
  • 通信作者: 华毛

Progress in diagnosis and treatment of overlap between asthma and chronic obstructive pulmonary disease

Ruili Li1, Mao Hua2(), Xiying Feng2   

  • Received:2017-05-22 Published:2017-10-20
  • Corresponding author: Mao Hua
引用本文:

李瑞丽, 华毛, 冯喜英, 马维秀, 李寒. 哮喘-慢性阻塞性肺疾病重叠的诊疗进展[J]. 中华肺部疾病杂志(电子版), 2017, 10(05): 597-600.

Ruili Li, Mao Hua, Xiying Feng. Progress in diagnosis and treatment of overlap between asthma and chronic obstructive pulmonary disease[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2017, 10(05): 597-600.

1
朱燕亭,宋旸,李少军,等. 哮喘与慢性阻塞性肺疾病重叠综合征的研究进展[J/CD]. 中华肺部疾病杂志(电子版), 2015, 8(3): 377-379.
2
李超,方圆,李志奎. 哮喘-COPD重叠综合症相关性疾病166例分析[J/CD]. 中华肺部疾病杂志(电子版), 2015, 8(6): 704-709.
3
颜文杰,宋勇. 哮喘-慢性阻塞性肺疾病重叠综合征研究的进展[J/CD]. 中华肺部疾病杂志(电子版), 2017, 10(3): 356-357.
4
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease ( Updated 2014 ) .

URL    
5
Global strategy for asthma management and prevention 2014(revision).

URL    
6
Global Strategy for the Diagnosis, Management and Prevention of COPD,Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2015

URL    
7
Global Initiative for Asthma. Global strategy for asthma management and prevention. Updated 2017. Vancouver, USA GINA; 2017.
8
Menezes AMB, Montes de Oca M, Pérez-Padilla R, et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype:COPDAsthma[J]. Chest, 2014, 145(2): 297-304.
9
Postma DS, Rabe KF. The Asthma-COPD Overlap Syndrome[J]. N Engl J Med, 2015, 373(13): 1241-1249.
10
Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD:what are its features and how important is it? [J]. Thorax, 2009, 64(8): 728-735.
11
Hakonarson H, Carter C, Kim C, et al. Altered expression and action of the low-affinity IgE receptor FcepsilonRII (CD23) in asthmatic airway smooth muscle[J]. J Allergy Clin Immunol, 1999, 104(1): 575-584.
12
Postma DS, Rabe KF. The asthma-COPD overlap syndrome[J]. N Engl J Med, 2015, 373(13): 1241-1249.
13
Gelb AF, Yamamoto A, Verbeken EK, et al. Unraveling the pathophysiology of the asthma-COPD overlap syndrome: un-suspected mild centrilobular emphysema Is responsible for loss of lung elastic recoil in never smokers with asthma with persistent expiratory airflow limitation[J]. Chest, 2015, 148(2): 313-320.
14
Christenson SA, Steiling K, van den Berge M, et al. Asthma-COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2015, 191(7): 758-766.
15
Hardin M, Cho M, McDonald ML, et al. The clinical and genetic features of COPD-asthma overlap syndrome[J]. Eur Respir J, 2014, 44(2): 341-350.
16
Smolonska J, Koppelman GH, Wijmenga C, et al. Common genes underlying asthma and COPD? Genome-wide analysis on the Dutch hypothesis[J]. Eur Respir J, 2014, 44(4): 860-872.
17
McDonough JE, Yuan R, Suzuki M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease[J]. N Engl J Med, 2011, 365(17): 1567-1575.
18
Sunil VR, Patel KJ, Mainelis G, et al. Pulmonary effects of inhaled diesel exhaust in aged mice[J]. Toxicol Appl Pharmacol, 2009, 241(3): 283-293.
19
Erzurum SC. New Insights in Oxidant Biology in Asthma[J]. Ann Am Thorac Soc, 2016, 13(Suppl 1): S35-S39.
20
Kalinina EP, Denisenko YK, Vitkina TI, et al. The Mechanisms of the Regulation of Immune Response in Patients with Comorbidity of Chronic Obstructive Pulmonary Disease and Asthma[J]. Can Respir J, 2016, 2016(6): 1-8.
21
Kobayashi S, Hanagama M, Yamanda S, et al. Inflammatory biomarkers in asthma-COPD overlap syndrome[J]. Int J Chron Obstruct Pulmon Dis, 2016, 11(1): 2117-2123.
22
Brzostek D, Kokot M. Asthma-chronic obstructive pulmonary disease overlap syndrome in Poland. Findings of an epidemiological study [J]. Postepy Dermatol Alergol, 2014, 31(6): 372-379.
23
Chung WS, Lin CL, Kao CH. Comparison of Acute Respiratory Events between Asthma-COPD Overlap Syndrome and COPD Patients: A Population-Based Cohort Study[J]. Medicine (Baltimore), 2015, 94(17): e755.
24
Yeh JJ, Wang YC, Kao CH. Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome Associated with Risk of Pulmonary Embolism[J]. PLoS One, 2016, 11(9): e0162483.
25
Yeh JJ, Wang YC, Kao CH. Asthma-Chronic Obstructive Pulmonary Diseases Overlap Syndrome Increases the Risk of Incident Tuberculosis: A National Cohort Study[J]. Plos One, 2016, 11(7): e0159012.
26
Soler-Cataluña JJ, Cosío B, Izquierdo JL, et al. Consensus document on the overlap phenotype COPD-asthma in COPD[J]. Arch Bronconeumol, 2012, 48(9): 331-337.
27
Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). Updated 2016.

URL    
28
Cheng SL, Lin CH. Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts[J]. Int J Chron Obstruct Pulmon Dis, 2016, 11(1): 2341-2348.
29
Castiglia D, Battaglia S, Benfante A, et al. Pharmacological management of elderly patients with asthma-chronic obstructive pulmonary disease overlap syn-drome: room for speculation?[J]. Drugs Aging, 2016, 33(6):375-385.
30
Lapperre TS, Snoeck-Stroband JB, Gosman MM, et al. Effect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: a randomized trial[J]. Ann Intern Med, 2009, 151(8): 517-527.
31
Antoniu SA. Targeting 5-lipoxygenase-activating protein in asthma and chronic obstructive pulmonary disease[J]. Expert Opin Ther Targets, 2014, 18(11): 1285-1292.
32
Nakawah MO, Hawkins C, Barbandi F. Asthma, Chronic Obstructive Pulmonary Disease (COPD), and the Overlap Syndrome[J]. J Am Board Fam Med, 2013, 26(4): 470-477.
33
Louie S, Zeki AA, Schivo M, et al. The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations[J]. Expert Rev Clin Pharmacol, 2013, 6(2): 197-219.
34
Ding B, Enstone A. Asthma and chronic obstructive pulmonary disease overlap syndrome (ACOS): structured literature review and physician insights[J]. Expert Rev Respir Med, 2016, 10(3): 363-371.
35
Segreti A, Stirpe E, Rogliani P, et al. Defining phenotypes in COPD: anaid to personalized healthcare[J]. Mol Diagn Ther, 2014, 18(4): 381-388.
[1] 陈腊青, 林佳佳, 毛洪刚, 童冠海, 汪梦娜, 夏红波, 刘卓, 徐海霞, 赵玉华, 张传领. 血清细胞因子及呼出气一氧化氮在哮喘-慢性阻塞性肺疾病重叠综合征中的临床意义[J]. 中华危重症医学杂志(电子版), 2023, 16(04): 316-320.
[2] 周杉京, 诸葛金科, 王芳芳. 补肺活血胶囊对COPD患者cCor、ALD、Ang-Ⅱ的影响[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 517-519.
[3] 吴庆华, 冒勇, 闫效坤. AECOPD并发AKI的危险因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 529-531.
[4] 芦丹, 杨硕, 刘旭. VEGF、HMGB1、hs-CRP/Alb在AECOPD伴呼吸衰竭中的变化及预后分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 532-534.
[5] 熊锋, 娄建丽. 慢性阻塞性肺疾病急性加重期预后的临床分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 550-553.
[6] 王庆, 张红联, 吴志勇. COPD合并多重耐药菌肺部感染预后危险因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 557-559.
[7] 林静, 陈芳, 刘小霞. COPD患者认知功能障碍影响因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 569-571.
[8] 张七妹, 麦宜准, 蒋浩波. 喘可治对慢性阻塞性肺疾病缓解期的临床分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 578-580.
[9] 张林, 刘芳, 赵静, 刘勇, 周青. 远程康复在慢性阻塞性肺疾病患者肺康复中的研究进展[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 601-604.
[10] 唐英俊, 李华娟, 王赛妮, 徐旺, 刘峰, 李羲, 郝新宝, 黄华萍. 人脐带间充质干细胞治疗COPD小鼠及机制分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 476-480.
[11] 徐丽玲, 卢玉宝, 赵彦, 任利, 李姝艺, 符娟, 康玲, 汪青松, 尤再春. COPD管理云平台的构建及临床应用[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 481-484.
[12] 李海明, 刘鸿飞, 李俊. 血清脂蛋白酶水平与COPD患者骨骼肌质量减少的关系[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 500-503.
[13] 廖玥, 王可, 秦江月, 吴艳秋, 陈俊, 汪涛, 文富强, 王浩. 丹龙口服液治疗轻中度慢性阻塞性肺疾病急性加重期的多中心及前瞻性研究[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 306-311.
[14] 张译梵, 张海华, 王瑛, 高贵洲, 王晓东, 屈林, 张涛. 陕西省成人慢性阻塞性肺疾病危险因素及预测模型[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 312-317.
[15] 谭玲芳, 周克兵. 基于生物信息学整合鉴定与支气管哮喘相关的潜在诊断生物标志物[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 329-334.
阅读次数
全文


摘要